Dana-Farber Cancer Institute, USA
Jean Zhao is Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School (HMS) and Dana-Farber Cancer Institute (DFCI). Prof. Zhao research centers on understanding kinase signaling pathways in cancer. She has pioneered a new front of understanding signal transduction by integrating mouse genetics and pharmacological approaches. Her work has laid the foundation for the selective targeting of PI3K isoforms in cancer, guiding the design of current and future clinical trials of PI3K inhibitors. Prof. Zhao continues to devote her extensive experience and expertise in mouse genetics and targeted therapeutics to immuno-oncology, and to the development of novel, safe and effective targeted and immunotherapy combinations for cancer. Prof. Zhao has been highly recognized for her innovative research and excellence in the field of cancer research. She received her PhD from Tufts Medical School in 1999 and completed her postdoctoral research with Dr. Thomas Roberts at Dana-Farber. Prof. Zhao joined Harvard Medical School in 2006 as Independent Principle Investigator. Her honors and awards include Career Development Awards from NIH/NCI, V Scholar Award, Starr Foundation Award and, recently, Outstanding Investigator Award from NIH/NCI. She is a member of the Executive Committee for Research, the Breast Cancer Steering Committee and the Committee for Women Faculty at DFCI, and serves as Co-Leader of the Breast Cancer Program at Dana-Farber/Harvard Cancer Center. She is also a national and international leader in the scientific community. She has served in key roles at Keystone Symposia, National Brain Tumor Society, and American Association for Cancer Research.